Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Change in Receivables (2016 - 2019)

Aptevo Therapeutics' Change in Receivables history spans 5 years, with the latest figure at -$896000.0 for Q4 2019.

  • For Q4 2019, Change in Receivables changed N/A year-over-year to -$896000.0; the TTM value through Dec 2019 reached $1.8 million, changed N/A, while the annual FY2019 figure was $1.8 million, 41.47% down from the prior year.
  • Change in Receivables for Q4 2019 was -$896000.0 at Aptevo Therapeutics, down from $540000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $5.1 million in Q2 2016 and bottomed at -$5.9 million in Q4 2015.
  • The 5-year median for Change in Receivables is $957000.0 (2018), against an average of $330117.6.
  • The largest annual shift saw Change in Receivables plummeted 657.73% in 2016 before it surged 878.05% in 2018.
  • A 5-year view of Change in Receivables shows it stood at -$5.9 million in 2015, then soared by 122.57% to $1.3 million in 2016, then increased by 21.74% to $1.6 million in 2017, then soared by 151.77% to $4.1 million in 2018, then plummeted by 122.06% to -$896000.0 in 2019.
  • Per Business Quant, the three most recent readings for APVO's Change in Receivables are -$896000.0 (Q4 2019), $540000.0 (Q3 2019), and $1.6 million (Q2 2019).